AEON Biopharma, Inc.
AEON
$0.24
$0.000.60%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.43M | 6.24M | 3.01M | 5.93M | 8.44M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 562.00K | 382.00K | 392.00K | 1.49M | 1.82M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.99M | 6.63M | 3.40M | 7.41M | 10.26M |
|
|
|||||
| Total Current Assets | 3.99M | 6.63M | 3.40M | 7.41M | 10.26M |
| Net Property, Plant & Equipment | 1.05M | 1.13M | 1.21M | 1.29M | 1.37M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 863.00K | 871.00K | 948.00K | 29.00K | 29.00K |
| Total Assets | 5.91M | 8.63M | 5.56M | 8.73M | 11.66M |
|
|
|||||
| Total Accounts Payable | 2.70M | 1.48M | 942.00K | 2.53M | 3.91M |
| Total Accrued Expenses | 4.38M | 4.93M | 5.70M | 5.46M | 4.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 263.00K | 258.00K | 252.00K | 247.00K | 242.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.34M | 6.67M | 6.90M | 8.23M | 9.13M |
|
|
|||||
| Total Current Liabilities | 7.34M | 6.67M | 6.90M | 8.23M | 9.13M |
| Long-Term Debt | 1.76M | 1.54M | 34.60M | 17.05M | 15.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 757.00K | 825.00K | 893.00K | 957.00K | 1.02M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.42M | 16.35M | 18.20M | 2.37M | 2.19M |
| Total Liabilities | 21.27M | 25.38M | 60.59M | 28.61M | 27.51M |
|
|
|||||
| Common Stock & APIC | 468.41M | 465.86M | 415.79M | 413.81M | 413.29M |
| Retained Earnings | -483.77M | -482.61M | -470.82M | -433.68M | -429.14M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -15.36M | -16.75M | -55.03M | -19.87M | -15.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.36M | -16.75M | -55.03M | -19.87M | -15.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.36M | -16.75M | -55.03M | -19.87M | -15.85M |
|
|
|||||